IVERIC bio Inc. Stock
IVERIC bio Inc. Stock
Our community identified positive and negative aspects for IVERIC bio Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the IVERIC bio Inc. stock. On the other hand our users think that "Management" could be a problem in the future.
Pros and Cons of IVERIC bio Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
B****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of IVERIC bio Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
IVERIC bio Inc. | - | - | - | - | - | - | - |
Jaguar Health Inc. | 1.070% | 4.624% | 129.565% | 102.558% | 4.901% | -99.947% | - |
Vaxart Inc. | -1.080% | -18.881% | -42.777% | 0.718% | 27.909% | -85.688% | - |
aTyr Pharma Inc | 2.040% | 1.351% | -21.466% | -12.791% | 16.279% | -54.268% | -78.399% |
Comments
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat